Skip to main content
Log in

Urinary selenium excretion in patients with cervical uterine cancer

  • Published:
Biological Trace Element Research Aims and scope Submit manuscript

Abstract

In this work, we report on a relationship between urinary selenium and the development of cervical uterine cancer. A simple chemical method was developed to concentrate trace amounts of selenium from relatively large urine samples by use of small activated carbon filters. When these filters are irradiated with thermal neutrons, selenium can be determined either by 77mSe (t 1/2=17.5 s) or 75Se (t 1/2=120 d). In this article, we report the results for 82 urine samples from women with cervical uterine cancer in several stages of development and from healthy controls. These results show a statistically significant increase of selenium excretion in cancer patients as compared to controls. Urinary selenium excretion is highest for patients in the intermediate stages of the disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. M. Simonoff and G. Simonoff, Le sélénium et la vie, Masson, Paris (1991).

    Google Scholar 

  2. G. N. Schrauzer, Selenium, mechanistic aspects of anticarcinogenic action, Biol. Trace Element Res. 33, 51–62 (1992).

    CAS  Google Scholar 

  3. A. N. Garg, V. Singh, R. G. Wegingwar, and V. N. Sagdeo, An elemental correlation study in cancerous and normal breast tissue with successive clinical stages by neutron activayion analysis, Biol. Trace Element Res. 46, 185–194 (1994).

    CAS  Google Scholar 

  4. M. Gerber, S. Richardson, R. Salked, and P. Chappuis, Antioxidants in female breast cancer patients, Cancer Inv. 9, 421–428 (1991).

    CAS  Google Scholar 

  5. M. M. El-Sharabasy, I. El-Dosaky, H. Horria, and A. H. Khalaf, Elevation of glutathione reductase and nucleic acids in both normal tissues and tumour of breast cancer patients, Cancer Lett. 72, 5–11 (1993).

    Article  Google Scholar 

  6. J. M. Navarrete, Analyse par activation du selenium dans des échantillons biologiques, en utilisant une méthode de pre-séparation des traces, Ph.D. thesis, Universite Paris VI (1992).

  7. M. Navarrete, L. Cabrera, N. Deschamps, N. Boscher, G. Revel, and A. Stampfler, Activation analysis of Se in biological samples through Se77m, J. Radioanal. Nucl. Chem. Lett. 145(6), 445–452 (1990).

    Article  CAS  Google Scholar 

  8. M. Navarrete, L. Cabrera, N. Deschamps, N. Boscher, G. Revel, J. P. Meyer, et al., Activation analysis of Se in organic samples, through Se-77m on a pre-separation basis, J. Radioanal. Nucl. Chem. Art. 168(1), 15–21 (1993).

    Article  CAS  Google Scholar 

  9. M. Navarrete, L. Cabrera, T. Martínez, G. Revel, J. P. Meyer, and A. Stampfler, Activation analysis of selenium in cancer research, J. Radioanal. Nucl. Chem. Art. 195, 91–95 (1995).

    Article  CAS  Google Scholar 

  10. M. Navarrete, L. Cabrera, T. Martínez, G. Revel, J. P. Meyer, and J. Guarner, Relationship between the cervical uterine cancer evolution and selenium concentration in urine determined by NAA, J. Radioanal. Nucl. Chem. Art. 217, 167–169 (1997).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Navarrete, M., Gaudry, A., Revel, G. et al. Urinary selenium excretion in patients with cervical uterine cancer. Biol Trace Elem Res 79, 97–105 (2001). https://doi.org/10.1385/BTER:79:2:97

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1385/BTER:79:2:97

Index Entries

Navigation